Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study.
about
Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancerMelanoma brain metastases: an unmet challenge in the era of active therapyPerillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain MetastasesSystemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.A nanoparticle carrying the p53 gene targets tumors including cancer stem cells, sensitizes glioblastoma to chemotherapy and improves survival.Phase II trial of temozolomide for leptomeningeal metastases in patients with solid tumors.Current approaches to the treatment of metastatic brain tumours.Progress in the biological understanding and management of breast cancer-associated central nervous system metastases.Profound prevention of experimental brain metastases of breast cancer by temozolomide in an MGMT-dependent manner.Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanomaThe A/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas.Neoplastic meningitis from solid tumors: new diagnostic and therapeutic approaches.Treatment of Breast Cancer Brain Metastases.Development of a preclinical therapeutic model of human brain metastasis with chemoradiotherapy.Melanoma Brain Metastasis Pseudoprogression after Pembrolizumab Treatment.Cancer and the metastatic substrate.Temozolomide for treatment of brain metastases: A review of 21 clinical trials.Phase II trial of patupilone in patients with brain metastases from breast cancer.Combining stereotactic radiosurgery and systemic therapy for brain metastases: a potential role for temozolomideBrain metastases from prostate cancer: an emerging clinical problem with implications for the future therapeutic scenario.Optimal management of brain metastases from breast cancer. Issues and considerations.Treatment of brain metastases from HER-2-positive breast cancer: current status and new concepts.Brain metastasis: new opportunities to tackle therapeutic resistance.Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis.The current management of brain metastasis in melanoma: a focus on riluzole.Challenges in the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer with brain metastases.Effect of chemotherapy on survival after whole brain radiation therapy for brain metastases: a single-center retrospective analysis.Systemic treatment of brain metastases in HER2-positive breast cancer: current status and future directions.Metastatic melanoma to the brain: surgery and radiation is still the standard of care.Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastases.Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer.Phase I study of bendamustine with concurrent whole brain radiation therapy in patients with brain metastases from solid tumors.Clinical trial design in brain metastasis: approaches for a unique patient population.[Progress of treatments in non-small cell lung cancer with brain metastases].Meta-analysis of whole-brain radiotherapy plus temozolomide compared with whole-brain radiotherapy for the treatment of brain metastases from non-small-cell lung cancer.Therapie von Hirnmetastasen und Meningeosis neoplastica
P2860
Q26824799-469BB063-48F2-45AA-9FDB-9FF91459EF31Q26995622-C3DB456C-C05D-4259-AC2B-7B91BCBFA8BEQ28072442-CA7737BB-79C0-4DA7-AB0E-C3F6B4053709Q30239901-8E301867-F1A0-4DFF-A085-0D2295F5B536Q30412393-2C324D0C-C589-443D-AE42-C6FC3C6EC52EQ33401308-FECC996A-3BBE-47C9-AF99-519C442A11CBQ33696559-7B4B077D-8B4F-4B8C-8C38-64C6219F9563Q33777436-F8EA2A25-EA47-46ED-9FF3-0FEAC29BB57EQ33909294-1538E440-3C73-4023-92F0-348D0B987B3CQ34372972-653D5BF7-D20C-417B-8F03-E4DE6DD6384DQ34762265-5324794C-061B-4D61-8ADE-A618B9001029Q35584731-00283CDD-3008-4068-BD35-66DAFCF5B880Q36057858-4EEBFD25-2811-4F3F-AD2A-10597860E40AQ36820588-43A3A096-4141-4B6F-9A4E-5513EE6EA661Q36939922-7F58F1BA-AA8C-4A2D-AB44-FDDCFF1DA5F3Q37573461-AFC64AED-9011-4F46-A5C2-069BCA6BBD1AQ37576025-C3D8EB49-7DC8-49F6-8959-E4A9EDDD0964Q37641250-ACCD0BD7-AA8E-4622-B59D-2FE6AE0E4AD9Q38036217-B6A7CB7D-3508-4EF0-BE6B-95C2699B3F5DQ38066590-92048BC9-B783-4362-95D6-304E15051F5BQ38067340-4E2AE1C2-640B-4808-A2C5-27B991C7F397Q38155202-DD4ED77E-95CD-4C9E-8D3B-2F3F28AA8C35Q38222247-0E31D73E-054F-421E-B918-152BE0FE23C8Q38369616-82767BCB-5902-4EB2-97EA-B0EEA039FD5DQ38532696-83115B0E-4F74-43F7-9D1A-E28E76D16BB2Q38792519-F0CB88E8-2DF7-4E86-A692-436129E5F328Q39637384-05D0D63C-27D7-452F-B24A-33D163AE5351Q39652258-5C876F04-DD3E-4D60-BC07-E14022DB9851Q48121721-98FC5B32-7BE8-46C9-B9C7-69FF50171599Q48401767-2C12FE4B-5870-4EA8-91F9-E08AF11423FCQ48471112-0D4D6DAA-319A-4E09-8D1C-4B26C5D2F49AQ48695471-6F313B96-DF71-4377-B4C8-2798D59D27E5Q48806386-5C49A222-608B-4A93-8456-C475CA0E32F0Q54509712-01249444-2A19-491B-84AD-535BDD0BFC17Q54942365-83C7FDA0-1C03-4682-AA29-519477DF28E9Q58023833-EFC6E376-24DE-4D86-BEF3-462DB304C9FF
P2860
Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Dose-dense temozolomide regime ...... a multicenter phase II study.
@ast
Dose-dense temozolomide regime ...... a multicenter phase II study.
@en
type
label
Dose-dense temozolomide regime ...... a multicenter phase II study.
@ast
Dose-dense temozolomide regime ...... a multicenter phase II study.
@en
prefLabel
Dose-dense temozolomide regime ...... a multicenter phase II study.
@ast
Dose-dense temozolomide regime ...... a multicenter phase II study.
@en
P2093
P2860
P50
P356
P1433
P1476
Dose-dense temozolomide regime ...... : a multicenter phase II study
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDP343
P577
2009-09-18T00:00:00Z